Update of the Mexican College of Rheumatology Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis

被引:33
|
作者
Cardiel, Mario H. [1 ]
Diaz-Borjon, Alejandro [2 ]
del Mercado Espinosa, Monica Vazquez [3 ,4 ,5 ]
Ivan Gamez-Nava, Jorge [4 ,6 ]
Barile Fabris, Leonor A. [7 ]
Pacheco Tena, Cesar [8 ]
Silveira Torre, Luis H. [9 ]
Pascual Ramosh, Virginia [10 ]
Goycochea Roblesi, Maria Victoria [11 ]
Aguilar Arreola, Jorge Enrique [3 ,4 ]
Gonzalez Diaz, Veronica [12 ]
Alvarez Nemegyei, Jose [13 ]
del Carmen Gonzalez-Lopez, Laura [4 ,14 ]
Salazar Paramon, Mario [15 ]
Portela Hernandez, Margarita [16 ]
Castro Colin, Zully [17 ]
Xibille Friedman, Daniel Xavier [18 ]
Alvarez Hernandez, Everardo [19 ]
Casasola Vargas, Julio [19 ]
Cortes Hernandez, Miguel [20 ]
Flores-Alvarado, Diana E. [21 ]
Martinez Martinez, Laura A. [22 ]
Vega-Morales, David [23 ]
Felipe Flores-Suarez, Luis [24 ]
Medrano Ramirez, Gabriel [25 ,26 ]
Barrera Cruz, Antonio [27 ,28 ]
Garcia Gonzalez, Adolfo [29 ]
Lopez Lopez, Susana Marisela [30 ]
Rosete Reyes, Alejandra [31 ]
Espinosa Morales, Rolando [32 ,33 ]
机构
[1] Hosp Gen Dr Miguel Silva, Secretaria Salud Michoacan, Unidad Invest Dr Mario Alvizouri Munoz, Morelia, Michoacan, Mexico
[2] UNAM, Hosp Angeles Lomas, Curso Especializac Med Interna, Huixquilucan, Estado De Mexic, Mexico
[3] Nuevo Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico
[4] Univ Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Jalisco, Mexico
[5] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculo Esquelet, Guadalajara, Jalisco, Mexico
[6] UMAE, IMSS, Hosp Especialidades Ctr Med Nacl Occidente, Guadalajara, Jalisco, Mexico
[7] Dept Reumatol HE CMNSXXI IMSS, Mexico City, DF, Mexico
[8] Univ Autonoma Chihuahua, Fac Med, Chihuahua, Mexico
[9] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Curso Reumatol, Mexico City, DF, Mexico
[10] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Inmunol & Reumatol, Mexico City, DF, Mexico
[11] IMSS, Hosp Gen Reg Dr Carlos McGregor Sanchez Navarro 1, Unidad Invest Epidemiol Clin, Mexico City, DF, Mexico
[12] Antiguo Hosp Civil Guadalajara Fray Antonio Alcal, Guadalajara, Jalisco, Mexico
[13] Univ Anahuac Mayab, Escuela Med, Merida, Yucatan, Mexico
[14] Hosp Gen Reg 110 IMSS, Guadalajara, Jalisco, Mexico
[15] UMAE, Div Invest, Hosp Especialidades Ctr Med Nacl Occidente, IMSS, Guadalajara, Jalisco, Mexico
[16] Hosp Especialidades CMN SXXI, Dept Reumatol, Mexico City, DF, Mexico
[17] HGZ 27 IMSS, Dept Reumatol, Mexico City, DF, Mexico
[18] Hosp Gen Cuernavaca Dr Jose G Parres, Dept Reumatol, Cuernavaca, Morelos, Mexico
[19] Hosp Gen Mexico City, Mexico City, DF, Mexico
[20] Univ Autonoma Estado Morelos, Fac Med, Fisiol Humana, Cuernavaca, Morelos, Mexico
[21] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Med Interna & Reumatol, Monterrey, Nuevo Leon, Mexico
[22] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Mexico City, DF, Mexico
[23] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Monterrey, Nuevo Leon, Mexico
[24] Inst Nacl Enfermedades Resp, Clin Vasculitis Sistem Primarias, Mexico City, DF, Mexico
[25] Hosp Gen Mexico City, Serv Reumatol, Mexico City, DF, Mexico
[26] Consejo Mexicano Reumatol, Mexico City, DF, Mexico
[27] IMSS, Unidades Med Alta Especialidad, Programas Med, Mexico City, DF, Mexico
[28] IMSS, Unidades Med Alta Especialidad, Div Excelencia Clin, Area Desarrollo Guias Pract Clin Coordinac, Mexico City, DF, Mexico
[29] Hosp Gen Zona IMSS, Ciencias Med, La Paz, Baja California, Mexico
[30] Hosp Angeles del Carmen, Serv Reumatol, Guadalajara, Jalisco, Mexico
[31] Ctr Invest Farmacol & Biotecnol, Operac, Mexico City, DF, Mexico
[32] Univ Nacl Autonoma Mexico, Reumatol, Mexico City, DF, Mexico
[33] Inst Nacl Rehabil, Dept Reumatol, Mexico City, DF, Mexico
来源
REUMATOLOGIA CLINICA | 2014年 / 10卷 / 04期
关键词
Rheumatoid arthritis; Drug therapy; Adult; Arthritis medical care;
D O I
10.1016/j.reuma.2013.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The pharmacologic management of rheumatoid arthritis has progressed substantially over the past years. It is therefore desirable that existing information be periodically updated. There are several published international guidelines for the treatment of rheumatoid arthritis that hardly adapt to the Mexican health system because of its limited healthcare resources. Hence, it is imperative to unify the existing recommendations and to incorporate them to a set of clinical, updated recommendations; the Mexican College of Rheumatology developed these recommendations in order to offer an integral management approach of rheumatoid arthritis according to the resources of the Mexican health system. Objective: To review, update and improve the available evidence within clinical practice guidelines on the pharmacological management of rheumatoid arthritis and produce a set of recommendations adapted to the Mexican health system, according to evidence available through December 2012. Methods: The working group was composed of 30 trained and experienced rheumatologists with a high quality of clinical knowledge and judgment. Recommendations were based on the highest quality evidence from the previously established treatment guidelines, meta-analysis and controlled clinical trials for the adult population with rheumatoid arthritis. Results: During the conformation of this document, each working group settled the existing evidence from the different topics according to their experience. Finally, all the evidence and decisions were unified into a single document, treatment algorithm and drug standardization tables. Conclusions: his update of the Mexican Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis provides the highest quality information available at the time the working group undertook this review and contextualizes its use for the complex Mexican health system. (C) 2013 Elsevier Espana, S.L.All rights reserved.
引用
收藏
页码:227 / 240
页数:14
相关论文
共 50 条
  • [31] Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment
    Sicong Huang
    Vanessa L. Kronzer
    Paul F. Dellaripa
    Kevin D. Deane
    Marcy B. Bolster
    Vivek Nagaraja
    Dinesh Khanna
    Tracy J. Doyle
    Jeffrey A. Sparks
    Current Treatment Options in Rheumatology, 2020, 6 : 337 - 353
  • [32] The process of collecting and evaluating evidences for the development of Guidelines for the management of rheumatoid arthritis, Japan College of Rheumatology 2014: Utilization of GRADE approach
    Kojima, Masayo
    Nakayama, Takeo
    Kawahito, Yutaka
    Kaneko, Yuko
    Kishimoto, Mitsumasa
    Hirata, Shintaro
    Seto, Yohei
    Endo, Hirahito
    Ito, Hiromu
    Kojima, Toshihisa
    Nishida, Keiichiro
    Matsushita, Isao
    Tsutani, Kiichiro
    Igarashi, Ataru
    Kamatani, Naoyuki
    Hasegawa, Mieko
    Miyasaka, Nobuyuki
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2016, 26 (02) : 175 - 179
  • [33] Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment
    Huang, Sicong
    Kronzer, Vanessa L.
    Dellaripa, Paul F.
    Deane, Kevin D.
    Bolster, Marcy B.
    Nagaraja, Vivek
    Khanna, Dinesh
    Doyle, Tracy J.
    Sparks, Jeffrey A.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (04) : 337 - 353
  • [34] 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis
    Henrique da Mota, Licia Maria
    Cruz, Boris Afonso
    Brenol, Claiton Viegas
    Pereira, Ivanio Alves
    Rezende-Fronza, Lucila Stange
    Bertolo, Manoel Barros
    Carioca de Freitas, Max Victor
    da Silva, Nilzio Antonio
    Louzada-Junior, Paulo
    Neubarth Giorgi, Rina Dalva
    Correa Lima, Rodrigo Aires
    Castelar Pinheiro, Geraldo da Rocha
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (02) : 135 - 174
  • [35] Guidelines for the use of biologic therapies in rheumatoid arthritis - December 2006 update
    ACTA REUMATOLOGICA PORTUGUESA, 2007, 32 (01): : 39 - +
  • [36] 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
    Fautrel, Bruno
    Kedra, Joanna
    Rempenault, Claire
    Juge, Pierre-Antoine
    Drouet, Juliette
    Avouac, Jerome
    Baillet, Athan
    Brocq, Olivier
    Alegria, Guillermo Carvajal
    Constantin, Arnaud
    Dernis, Emmanuelle
    Gaujoux-Viala, Cecile
    Goeb, Vincent
    Gottenberg, Jacques-Eric
    Le Goff, Benoit
    Marotte, Hubert
    Richez, Christophe
    Salmon, Jean-Hugues
    Saraux, Alain
    Senbel, Eric
    Seror, Raphaele
    Tournadre, Anne
    Vittecoq, Olivier
    Escaffre, Pascale
    Vacher, Danielle
    Dieude, Philippe
    Daien, Claire
    JOINT BONE SPINE, 2024, 91 (06)
  • [37] Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
    Koike, Ryuji
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Amano, Koichi
    Kawai, Shinichi
    Saito, Kazuyoshi
    Saito, Tomoyuki
    Yamamura, Masahiro
    Matsubara, Tsukasa
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2009, 19 (04) : 351 - 357
  • [38] Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance
    Gheita, Tamer A.
    Raafat, Hala A.
    El-Bakry, Samah A.
    Elsaman, Ahmed
    El-Saadany, Hanan M.
    Hammam, Nevin
    El-Gazzar, Iman I.
    Samy, Nermeen
    Elsaid, Nora Y.
    Al-Adle, Suzan S.
    Tharwat, Samar
    Ibrahim, Amira M.
    Fawzy, Samar M.
    Eesa, Nahla N.
    El Shereef, Rawhya
    Ismail, Faten
    Abd Elazeem, Mervat, I
    Abdelaleem, Enas A.
    El-Bahnasawy, Amany
    Selim, Zahraa, I
    Gamal, Nada M.
    Nassr, Maha
    Nasef, Samah, I
    Moshrif, Abdel Hafeez
    Elwan, Shereen
    Abdel-Fattah, Yousra H.
    Amer, Marwa A.
    Mosad, Doaa
    Mohamed, Eman F.
    EI-Essawi, Dina F.
    Taha, Hanan
    Salem, Mohamed N.
    Fawzy, Rasha M.
    Ibrahim, Maha E.
    Khalifa, Asmaa
    Abaza, Nouran M.
    Abdalla, Ahmed M.
    El-Najjar, Amany R.
    Azab, Noha A.
    Fathi, Hanan M.
    El-Hadidi, Khaled
    El-Hadidi, Tahsin
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (04) : 667 - 676
  • [39] Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication
    Kameda, Hideto
    Yamaoka, Kunihiro
    Yamanishi, Yuji
    Tada, Masahiro
    Koike, Ryuji
    Nakajima, Ayako
    Fusama, Mie
    Fujii, Takao
    MODERN RHEUMATOLOGY, 2023, 34 (01) : 1 - 10
  • [40] Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis
    Tornero Molina, Jesus
    Sanmarti Sala, Raimon
    Rodriguez Valverde, Vicente
    Martin Mola, Emilio
    Marenco de la Fuente, Jose Luis
    Gonzalez Alvaro, Isidoro
    Munoz Fernandez, Santiago
    Gomez-Reino Carnota, Juan
    Carreno Perez, Luis
    Battle Gualda, Enrique
    Balsa Criado, Alejandro
    Luis Andreu, Jose
    Maria Alvaro-Gracia, Jose
    Martinez Lopez, Juan Antonio
    Loza Santamaria, Estibaliz
    REUMATOLOGIA CLINICA, 2010, 6 (01): : 23 - 36